Asian Interchange on Diabetes
This Asian Interchange on Diabetes is in collaboration with PACE-CME and ACROSS T2D (Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes). During this Asian Interchange on Diabetes participants will receive a balanced review on how novel developments might impact their clinical practice in managing patients with T2DM.
Episodes 1-3 of 3
- Asian Interchange on DiabetesThe effect of treatment with DPP-4 inhibition on renal complications in diabetic patients.
Prof. Per-Henrik Groop
Prof. Per-Henrik Groop
Richard E. Pratley, MD
